Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 1 (4) , 535-540
- https://doi.org/10.1016/0924-977x(91)90007-h
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophreniaSchizophrenia Research, 1991
- A double-blind comparative trial of remoxipride and haloperidol in the treatment of schizophreniaHuman Psychopharmacology: Clinical and Experimental, 1990
- Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.Acta Psychiatrica Scandinavica, 1990
- Selective dopamine D2 antagonist, remoxipride,in the treatment of acute schizophrenia - results of proclactin studiesSchizophrenia Research, 1990
- Plasma Concentrations of Haloperidol and Prolactin and Clinical Outcome in Acutely Psychotic PatientsPharmacopsychiatry, 1988
- Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patientsJournal of Psychopharmacology, 1988
- Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic DrugsArchives of General Psychiatry, 1988
- Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patientsAmerican Journal of Psychiatry, 1982
- Low Serum Neuroleptic Levels Predict Relapse in Schizophrenic PatientsArchives of General Psychiatry, 1982
- Prolactin Responses to Neuroleptics in Normal and Schizophrenic SubjectsArchives of General Psychiatry, 1978